Acquired Amegakaryocytic Thrombocytopenia is a rare hematologic condition, with <50 cases reported. It is characterized by severe thrombocytopenia with complete absence or severe reduction of megakaryocytes in the bone marrow with otherwise normal hematopoiesis. Its mechanism is not fully understood but is suggested to be related to anti-thrombopoietin antibodies.